This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lagacé-Wiens, P. R. S.
Right arrow Articles by Harding, G. K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lagacé-Wiens, P. R. S.
Right arrow Articles by Harding, G. K. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2008, p. 1174-1177, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.01253-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Reductions in Workload and Reporting Time by Use of Methicillin-Resistant Staphylococcus aureus Screening with MRSASelect Medium Compared to Mannitol-Salt Medium Supplemented with Oxacillin{triangledown}

Philippe R. S. Lagacé-Wiens,1,2* Michelle J. Alfa,1,2,3 Kanchana Manickam,2,3 and Godfrey K. M. Harding1,2,3

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada,1 Clinical Microbiology, Saint-Boniface General Hospital, Winnipeg, Manitoba, Canada,2 Diagnostic Services of Manitoba, Winnipeg, Manitoba, Canada3

Received 21 June 2007/ Returned for modification 16 August 2007/ Accepted 22 January 2008

Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen in both nosocomial and community settings, and screening for carriers is an important infection control practice in many hospitals. In this retrospective study, we demonstrate that the implementation of an MRSA screening protocol using a selective chromogenic medium (MRSASelect) reduced the workload for this screening test by 63.7% overall and by 12.6% per specimen and reduced the turnaround time for reporting by an average of 1.33 days for all MRSA screening specimens, 1.97 days for MRSA-positive specimens, and 1.3 days for MRSA-negative specimens compared to standard mannitol-salt agar supplemented with 6 mg of oxacillin/liter.

* Corresponding author. Mailing address: Clinical Microbiology, Saint-Boniface General Hospital, Winnipeg, Manitoba R2H 2A6, Canada. Phone: (204) 237-2053. Fax: (204) 237-6065. E-mail: plagacewiens{at}hotmail.com

{triangledown} Published ahead of print on 30 January 2008.

Journal of Clinical Microbiology, April 2008, p. 1174-1177, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.01253-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»